FDA grants accelerated approval for targeted therapy for platinum-resistant gynecologic cancers. Nierengarten MB. Cancer 2023;129:656.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nierengarten MB. FDA grants accelerated approval for targeted therapy for platinum-resistant gynecologic cancers. Cancer 2023;129:656.
PMID: 36744309